在肥胖相关性高血压的治疗中，我们应该将交感神经系统作为靶点吗？ - Suppr

Suppr

超能文献

Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

作者信息

Biaggioni Italo

机构信息

Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.

出版信息

Hypertension. 2008 Feb;51(2):168-71. doi: 10.1161/HYPERTENSIONAHA.107.090514. Epub 2007 Dec 17.

DOI:10.1161/HYPERTENSIONAHA.107.090514

PMID:18086947

Abstract

摘要

相似文献

Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

Hypertension. 2008 Feb;51(2):168-71. doi: 10.1161/HYPERTENSIONAHA.107.090514. Epub 2007 Dec 17.

European Society of Hypertension Working Group on Obesity: background, aims and perspectives.

J Hypertens. 2007 Apr;25(4):897-900. doi: 10.1097/HJH.0b013e328051b510.

[How to treat effectively hypertensive patient with overactivity of sympathetic system?].

Pol Arch Med Wewn. 2002 Apr;107(4):349-59.

Effects of antihypertensive therapies on the sympathetic nervous system.

Can J Cardiol. 1999 Mar;15 Suppl A:8A-14A.

Neurogenic factors in hypertension: therapeutic implications.

Ann Ital Med Int. 1994 Oct;9 Suppl:39S-43S.

Sympathetic nervous system and insulin resistance: from obesity to diabetes.

Am J Hypertens. 2001 Nov;14(11 Pt 2):304S-309S. doi: 10.1016/s0895-7061(01)02236-1.

High blood pressure management: potential benefits of I1 agents.

J Hypertens Suppl. 1998 Aug;16(3):S19-24.

[Treatment of hypertension complicated by diabetes mellitus and obesity].

Nihon Naika Gakkai Zasshi. 1990 Jan 10;79(1):54-9.

Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.

Curr Opin Cardiol. 2002 Jul;17(4):355-9. doi: 10.1097/00001573-200207000-00006.

Neural mechanisms and management of obesity-related hypertension.

Curr Cardiol Rep. 2008 Nov;10(6):456-63. doi: 10.1007/s11886-008-0072-7.

引用本文的文献

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.

J Hypertens. 2024 Jan 1;42(1):23-49. doi: 10.1097/HJH.0000000000003563. Epub 2023 Sep 12.

Autonomic blockade improves insulin sensitivity in obese subjects.

Hypertension. 2014 Oct;64(4):867-74. doi: 10.1161/HYPERTENSIONAHA.114.03738. Epub 2014 Jul 7.

Metalloproteinases: key and common mediators of multiple GPCRs and candidate therapeutic targets in models of hypertensive cardiac disease.

Drug Discov Today Dis Models. 2012 Fall;9(3):e103-e108. doi: 10.1016/j.ddmod.2012.04.003.

Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?

Curr Hypertens Rev. 2012 Aug 1;8(3):159-180. doi: 10.2174/157340212803530420.

Clustering of the metabolic syndrome components in adolescence: role of visceral fat.

PLoS One. 2013 Dec 20;8(12):e82368. doi: 10.1371/journal.pone.0082368. eCollection 2013.

Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.

PLoS One. 2012;7(11):e48966. doi: 10.1371/journal.pone.0048966. Epub 2012 Nov 5.

Drug mechanisms to help in managing resistant hypertension in obesity.

Curr Hypertens Rep. 2010 Aug;12(4):220-5. doi: 10.1007/s11906-010-0123-5.

The role of the sympathetic nervous system in obesity-related hypertension.

Curr Hypertens Rep. 2009 Jun;11(3):206-11. doi: 10.1007/s11906-009-0036-3.

Sympathetic neural mechanisms in human hypertension.

Curr Hypertens Rep. 2008 Jun;10(3):241-7. doi: 10.1007/s11906-008-0045-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验